Get startedLog in
    Picture of Maat Pharma SA logo

    MAAT — Maat Pharma SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Euronext: Quarterly Review Of CAC Family

    Picture of Maat Pharma SA logoMaat Pharma SA
    11/09/2025 17:45
    Sept 11 (Reuters) - Pan-European stock exchange operator Euronext ENX.PA on Thursday announced its quarterly review of France's CAC family indices, effective from September 22.

Here are the main changes:

CAC 40 .FCHI


    Inclusion ofExclusion of
    EuronextTeleperformance
    

SBF 120 .SBF120


    Inclusion ofExclusion of
    AbivaxEsso
    Exail TechnologiesOVH
    

CAC NEXT 20


    Inclusion ofExclusion of
    Technip Energies N.V.Eurazeo SE
    TeleperformanceEuronext
    

CAC LARGE 60


    Inclusion ofExclusion of
    Technip Energies N.V.Eurazeo SE
    

CAC MID 60


    Inclusion ofExclusion of
    AbivaxEsso
    EurazeoOVH
    Exail TechnologiesTechnip Energies N.V.
    

CAC SMALL INDEX


    Inclusion ofExclusion of
    AbeoAbivax
    Aelis FarmaBalyo
    Antin Infrastructure PartnersBoiron
    AtemeCompagnie Chargeurs Invest
    EssoDekuple
    Explosifs Prod. ChiExail Technologies
    InfotelHaulotte Group
    Linedata Services
    Maat Pharma
    OVH
    TFF Group
    TotalEnergies EP Gabon
    Transgene
    Vetoquinol
    Viel et Compagnie
    Vranken Pommery
    

Source text: ID:nNDL98jjDC

Further company coverage: ENX.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Maat Pharma SA

    See all news